BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 11, 2017
View Archived Issues
Metacrine tests new farnesoid X-activated receptor agonist in NASH model
Read More
Armanezumab clears pathological Tau protein in mouse brains
Read More
Procathepsin D found as a diagnostic marker of malignant pleural effusion in lung cancer
Read More
Hepcidin knockout rats display iron overload
Read More
European Commission approves dinutuximab beta for the treatment of high-risk neuroblastoma
Read More
Adaptimmune Therapeutics begins AFP SPEAR T-cell study in HCC
Read More
FDA grants breakthrough therapy designation to vonapanitase from Proteon Therapeutics
Read More
First patient enrolled in phase I trial of Loxo Oncology's LOXO-292
Read More
Takeda and GammaDelta Therapeutics announce strategic collaboration
Read More
Leucyl-tRNA synthetase inhibitor from Dong-A ST potently inhibits Gram-negative bacteria
Read More
Polymorphism in ADRB1 impacts outcome in Marfan syndrome patients on atenolol
Read More
FDA grants fast track designation to Celyad's C-Cure
Read More
Astellas discontinues ASP-8273 treatment in SOLAR NSCLC trial
Read More
Vericel's ixmyelocel-T wins FDA regenerative medicine advanced therapy designation
Read More
Companies partner on E.U. managed access programs for niraparib and belinostat
Read More
A new rabbit model of respiratory distress syndrome managed on nCPAP
Read More
Savara receives FDA guidance on clinical requirements for Molgradex NDA
Read More
Longeveron cleared to continue phase I trial of LMSCs in Alzheimer's disease
Read More
Topline data reported from pivotal studies of mepolizumab for severe COPD
Read More
Shionogi reflects on accomplishments of fourth quarter of fiscal 2016
Read More
Jortan Pharmaceuticals discovers beta-secretase 2 inhibitors
Read More
NSAID derivatives patented by ratiopharm
Read More
AbGenomics initiates phase I study of ADC AbGn-107 in gastric, colorectal and pancreatic cancer
Read More
Sangamo and Pfizer collaborate on gene therapy programs for hemophilia A
Read More
FDA approves Keytruda in first-line combination therapy for metastatic nonsquamous NSCLC
Read More
Servier initiates phase I study of S-64315 in AML and MDS
Read More
Polymorphisms of the Wnt pathway associated with bronchopulmonary dysplasia in ELBW infants
Read More